Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like Israel’s life sciences firms said to raise record $1.5 billion in 2018 May 16, 2019 New VC fund to set sights on Israeli tech for eye diseases April 9, 2018 Call for company presentations and start-up companies March 11, 2019
